← Back to Search

Participants that Smoke for Tobacco Smoking

N/A

Recruiting

Led By Timothy McClintock, PhD

Research Sponsored by Tim McClintock

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 hours (total for all outcome measures)

Awards & highlights

Study Summary

This trial aims to find out if using blockers to reduce the smell of cigarette smoke can help people quit smoking. Participants will be asked to smell different odors and rate how pleasant they are and if it

Who is the study for?

This trial is for individuals who currently smoke cigarettes and can smell and taste normally. It's not suitable for non-smokers or those with a self-reported inability to smell or taste.Check my eligibility

What is being tested?

The study is testing whether certain substances, called odor blockers, can reduce the appeal of cigarette smoke by suppressing its perceived intensity, potentially helping smokers quit.See study design

What are the potential side effects?

Since this trial involves smelling odor samples without any ingestion or physical intervention, there are no direct side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 hours (total for all outcome measures)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 hours (total for all outcome measures)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 hours (total for all outcome measures) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cigarette Purchase Task

Desire to Smoke

Secondary outcome measures

Odor pleasantness score

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants that SmokeExperimental Treatment1 Intervention

Each smoker is asked to smell up to 20 samples per session. Samples include controls (clean air, irrelevant odor), blocking odors, cigarette smoke, and cigarette smoke mixed with blocking odors or irrelevant odors.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Tim McClintockLead Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

330 Previous Clinical Trials

178,431 Total Patients Enrolled

Timothy McClintock, PhDPrincipal InvestigatorUniversity of Kentucky

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively enroll participants for this clinical trial?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is actively seeking eligible participants. The initial posting of the study was on January 1st, 2024, and it underwent its most recent update on December 20th, 2023. To fulfill the requirements of this trial, a total of 40 patients will be enrolled from a single designated site."

Answered by AI

What is the total number of participants being recruited for this clinical investigation?

"Indeed, the current information available on clinicaltrials.gov indicates that this clinical trial is actively seeking eligible candidates. The initial posting date of the trial was January 1st, 2024, and it was last updated on December 20th, 2023. In total, the trial aims to enroll a cohort of 40 participants from a single designated site."

Answered by AI

Can individuals who have surpassed the age of 25 participate in this medical study?

"Prospective participants in this trial must be within the age range of 18 to 60. Additionally, there are separate trials available for individuals under 18 (6 trials) and those over 65 (44 trials)."

Answered by AI